However, there is scarce evidence from population-representative samples of long-term heavy smokers to indicate whether cTnI measurements could be useful for identifying individuals at elevated risk of cardiac death in a lung cancer screening setting. This evidence concerns the gene TNNI3 and lung carcinoma.